WELL Health Announces Approval of Normal Course Issuer Bid
VANCOUVER, BC, June 6, 2024 /PRNewswire/ – WELL Health Technologies Corp. (TSX:WELL) (OTCQX: WHTCF) (“WELL” or the “Company“), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its Notice of Intention to Make a Normal Course Issuer Bid (“NCIB“) filed with the Toronto Stock Exchange (“TSX“) has been approved. The NCIB is a renewal of its NCIB that expired on June 4, 2024.
Related news for (WHTCF)
- WELL HEALTH TECHNOLOGIES CORP. EARLY WARNING NEWS RELEASE
- WELL Health Reports Record Results for Q2-2024 Driven by an Acceleration in Organic Growth and Raises Annual Guidance
- WELL Health’s Circle Medical Provides Corporate Update, Exceeds $100M USD Revenue Run Rate with Profitability and Positions for Further Growth
- WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease
- WELL Health Announces Approval for Historic $44M Project, the Largest DIGITAL Project Ever Awarded to Advance AI-powered Tech Enablement for Care Providers